§ Research summary · Mitochondrial

SLU-PP-332 5 mg

Also known as · SLU-PP-332

Mitochondrial·1 min read·reviewed 2026-05-07

SLU-PP-332 is a small-molecule pan-ERR (estrogen-related receptor) agonist developed by the Burris lab. Preclinical metabolic-research tool.

Chemistry quick-facts

CAS
1334513-02-8
Formula
C18H13F3N2O3S
MW
394.37 Da
Status
Preclinical research tool from the Burris laboratory. No clinical trials.
Purity (HPLC)
≥ 98.0%

Mechanism of action

Pan-agonism at estrogen-related receptor family (ERRα / β / γ) → transcriptional activation of mitochondrial-biogenesis programmes.

Research context

SLU-PP-332 is a small-molecule agonist of the ERRα / β / γ nuclear receptors, developed by the Burris laboratory at Saint Louis University. Published preclinical work (2023) demonstrated metabolic effects in mice, including exercise-mimetic activity.

Published studies

A non-exhaustive list of peer-reviewed studies referenced when curating this entry. Click through to the primary source for the full text.

  1. Billon C, Sitaula S, Banerjee S, et al. (2023). Synthetic ERR agonists induce the phenotype of endurance exercise. Science Advances.

Reconstitution

Solvent
DMSO for in vitro stock solutions; aqueous co-solvent for in vivo
Typical volume
1 mL
  • · Small molecule — prepare cell-culture stock in DMSO per standard protocols.

Storage

Lyophilised
−20 °C, desiccated, protected from light. Stable at 15–25 °C for up to 30 days in transit.
Reconstituted
2–8 °C, original vial, consumed within 4 weeks.
Shelf life — sealed
24 months from date of manufacture when stored lyophilised at −20 °C.
Research-use disclaimer

This page summarises the research literature on SLU-PP-332 5 mg for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.

View SLU-PP-332 5 mg in the catalogue →
§ Related reading